Pathophysiology of plaque instability: Insights at the genomic level

Neuza Lopes, Sanjay S. Vasudevan, Rene J. Alvarez, Philip F. Binkley, Pascal J. Goldschmidt

Research output: Contribution to journalArticle

11 Scopus citations


Atherosclerosis and plaque rupture represent complex "traits" of unknown cause that involve multiple genes and their variants. Novel genomic technologies provide us with the tools that will allow for the identification of groupings of genes that determine either susceptibility or resistance relative to the development of atherosclerosis and its thromboembolic complications. This information may, in turn, lead to a clearer understanding of the cause and risk for atherosclerosis. Diagnostic tools, as well as preventive and therapeutic strategies, will be derived from such heightened understanding of the disease process. With this chapter, we have presented the current state of knowledge of atherosclerosis genomics.

Original languageEnglish (US)
Pages (from-to)323-338
Number of pages16
JournalProgress in Cardiovascular Diseases
Issue number5
StatePublished - Jan 1 2002


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lopes, N., Vasudevan, S. S., Alvarez, R. J., Binkley, P. F., & Goldschmidt, P. J. (2002). Pathophysiology of plaque instability: Insights at the genomic level. Progress in Cardiovascular Diseases, 44(5), 323-338.